| scholarly article | Q13442814 |
| P2093 | author name string | Francesco Beguinot | |
| Alessandra Trencia | |||
| Angela Cassese | |||
| Anna Perfetti | |||
| Claudia Miele | |||
| Francesco Oriente | |||
| Giovanni Vigliotta | |||
| Pietro Formisano | |||
| Stefania Santopietro | |||
| Chiara Romano | |||
| Giancarlo Troncone | |||
| Cecilia Tiveron | |||
| Giuseppe Portella | |||
| Francesca Fiory | |||
| Laura Tatangelo | |||
| Maria Alessandra Maitan | |||
| P2860 | cites work | PED/PEA-15: an anti-apoptotic molecule that regulates FAS/TNFR1-induced apoptosis | Q22003766 |
| PED/PEA-15 gene controls glucose transport and is overexpressed in type 2 diabetes mellitus | Q24316231 | ||
| Protein kinase B/Akt binds and phosphorylates PED/PEA-15, stabilizing its antiapoptotic action | Q24683017 | ||
| Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 | Q25938983 | ||
| Regulation of expression of phospholipase D1 and D2 by PEA-15, a novel protein that interacts with them | Q28142706 | ||
| PEA-15 mediates cytoplasmic sequestration of ERK MAP kinase | Q28204643 | ||
| Multiple members of the mitogen-activated protein kinase family are necessary for PED/PEA-15 anti-apoptotic function | Q28215522 | ||
| Tumor necrosis factor-related apoptosis-inducing ligand-induced death-inducing signaling complex and its modulation by c-FLIP and PED/PEA-15 in glioma cells | Q28215810 | ||
| Failure of insulin-regulated recruitment of the glucose transporter GLUT4 in cardiac muscle of obese Zucker rats is associated with alterations of small-molecular-mass GTP-binding proteins | Q28577351 | ||
| The phosphoprotein protein PEA-15 inhibits Fas- but increases TNF-R1-mediated caspase-8 activity and apoptosis | Q28587650 | ||
| Knockout of PKC alpha enhances insulin signaling through PI3K | Q28590618 | ||
| Banting lecture 1988. Role of insulin resistance in human disease | Q29547283 | ||
| Global and societal implications of the diabetes epidemic | Q29614551 | ||
| Normal insulin-dependent activation of Akt/protein kinase B, with diminished activation of phosphoinositide 3-kinase, in muscle in type 2 diabetes | Q33853693 | ||
| Mechanism of protein kinase B activation by cyclic AMP-dependent protein kinase | Q33958737 | ||
| Banting Lecture. Insulin action, diabetogenes, and the cause of type II diabetes | Q34330770 | ||
| Diabetes mellitus and genetically programmed defects in beta-cell function | Q34462316 | ||
| Insulin resistance in type 2 diabetes: role of fatty acids | Q34580981 | ||
| Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. | Q34655571 | ||
| Function and dysfunction of aPKC isoforms for glucose transport in insulin-sensitive and insulin-resistant states | Q34688703 | ||
| IRS proteins and the common path to diabetes | Q34778267 | ||
| Insulin action and the regulation of hexose transport | Q40284376 | ||
| Protein kinase C (PKC)-alpha activation inhibits PKC-zeta and mediates the action of PED/PEA-15 on glucose transport in the L6 skeletal muscle cells | Q40803281 | ||
| Establishment of a pancreatic beta cell line that retains glucose-inducible insulin secretion: special reference to expression of glucose transporter isoforms | Q41729392 | ||
| The IR1152 mutant insulin receptor selectively impairs insulin action in skeletal muscle but not in liver. | Q42491060 | ||
| Photoaffinity labelling of cardiac membrane GTP-binding proteins in response to insulin | Q42505170 | ||
| Rosiglitazone, insulin treatment, and fasting correct defective activation of protein kinase C-zeta/lambda by insulin in vastus lateralis muscles and adipocytes of diabetic rats | Q43543575 | ||
| Quantitative measurement of sn-1,2-diacylglycerols | Q45205999 | ||
| Tissue and isoform-selective activation of protein kinase C in insulin-resistant obese Zucker rats - effects of feeding. | Q51562050 | ||
| Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance. | Q52540333 | ||
| Induction and intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) mediated apotosis in human malignant glioma cells. | Q54018179 | ||
| 1,2-Diacylglycerol and ceramide levels in rat skeletal muscle and liver in vivo. Studies with insulin, exercise, muscle denervation, and vasopressin. | Q54324021 | ||
| Thiazolidinedione treatment enhances insulin effects on protein kinase C-zeta /lambda activation and glucose transport in adipocytes of nondiabetic and Goto-Kakizaki type II diabetic rats | Q73631016 | ||
| METABOLISM OF ISOLATED FAT CELLS. I. EFFECTS OF HORMONES ON GLUCOSE METABOLISM AND LIPOLYSIS | Q76853134 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | preproinsulin | Q7240673 |
| overexpression | Q61643320 | ||
| P304 | page(s) | 5005-5015 | |
| P577 | publication date | 2004-06-01 | |
| P1433 | published in | Molecular and Cellular Biology | Q3319478 |
| P1476 | title | Overexpression of the ped/pea-15 gene causes diabetes by impairing glucose-stimulated insulin secretion in addition to insulin action | |
| P478 | volume | 24 |
| Q42700870 | A peptide antagonist of Prep1-p160 interaction improves ceramide-induced insulin resistance in skeletal muscle cells. |
| Q34667784 | Adenoviral gene transfer of PLD1-D4 enhances insulin sensitivity in mice by disrupting phospholipase D1 interaction with PED/PEA-15. |
| Q34252924 | Age-related impairment in insulin release: the essential role of β(2)-adrenergic receptor |
| Q43565613 | Biomechanical insult switches PEA-15 activity to uncouple its anti-apoptotic function and promote erk mediated tissue remodeling |
| Q35001275 | Characterization of a MAPK scaffolding protein logic gate in gonadotropes. |
| Q35837406 | Clozapine impairs insulin action by up-regulating Akt phosphorylation and Ped/Pea-15 protein abundance |
| Q39541782 | Comparison between fibroblast wound healing and cell random migration assays in vitro |
| Q48206002 | Expression of phosphoprotein enriched in astrocytes 15 kDa (PEA-15) in astrocytic tumors: a novel approach of correlating malignancy grade and prognosis |
| Q43097133 | Hepatocyte nuclear factor (HNF)-4alpha-driven epigenetic silencing of the human PED gene. |
| Q43154745 | Molecular cloning and characterization of the human PED/PEA-15 gene promoter reveal antagonistic regulation by hepatocyte nuclear factor 4alpha and chicken ovalbumin upstream promoter transcription factor II. |
| Q42913727 | NMR backbone dynamics studies of human PED/PEA-15 outline protein functional sites |
| Q28476047 | Negative regulators of insulin signaling revealed in a genome-wide functional screen |
| Q26799216 | On the Quest of Cellular Functions of PEA-15 and the Therapeutic Opportunities |
| Q43269412 | Overproduction of phosphoprotein enriched in diabetes (PED) induces mesangial expansion and upregulates protein kinase C-beta activity and TGF-beta1 expression. |
| Q42272320 | PED/PEA-15 controls fibroblast motility and wound closure by ERK1/2-dependent mechanisms |
| Q36028460 | PED/PEA-15 induces autophagy and mediates TGF-beta1 effect on muscle cell differentiation |
| Q34663501 | PED/PEA-15 inhibits hydrogen peroxide-induced apoptosis in Ins-1E pancreatic beta-cells via PLD-1 |
| Q54408005 | PREP1 deficiency downregulates hepatic lipogenesis and attenuates steatohepatitis in mice. |
| Q42416060 | Parkinson-like phenotype in insulin-resistant PED/PEA-15 transgenic mice |
| Q36466778 | Peroxisome proliferator-activated receptor-γ activation enhances insulin-stimulated glucose disposal by reducing ped/pea-15 gene expression in skeletal muscle cells: evidence for involvement of activator protein-1 |
| Q53337896 | Phorbol esters induce intracellular accumulation of the anti-apoptotic protein PED/PEA-15 by preventing ubiquitinylation and proteasomal degradation. |
| Q34024181 | Phosphoprotein enriched in astrocytes (PEA)-15: a potential therapeutic target in multiple disease states |
| Q35190978 | Phosphoprotein enriched in astrocytes-15 kDa expression inhibits astrocyte migration by a protein kinase C delta-dependent mechanism |
| Q39652158 | Prep1 Controls Insulin Glucoregulatory Function in Liver by Transcriptional Targeting of SHP1 Tyrosine Phosphatase |
| Q36898758 | Prep1 deficiency induces protection from diabetes and increased insulin sensitivity through a p160-mediated mechanism. |
| Q40393314 | Raised expression of the antiapoptotic protein ped/pea-15 increases susceptibility to chemically induced skin tumor development. |
| Q46549512 | Targeting of PED/PEA-15 molecular interaction with phospholipase D1 enhances insulin sensitivity in skeletal muscle cells. |
| Q39232367 | Targetting PED/PEA-15 for diabetes treatment. |
| Q40093567 | The PEA-15/PED protein protects glioblastoma cells from glucose deprivation-induced apoptosis via the ERK/MAP kinase pathway. |
| Q51488380 | The PEA15 gene is overexpressed and related to insulin resistance in healthy first-degree relatives of patients with type 2 diabetes. |
| Q37112520 | The roles of MAPKs in disease |
| Q28564173 | Tyrosine phosphorylation of phosphoinositide-dependent kinase 1 by the insulin receptor is necessary for insulin metabolic signaling |
| Q38405367 | Understanding type 2 diabetes: from genetics to epigenetics |
Search more.